CD274 and pneumonitis: We speculated that this was possibly due to the predisposition of symptomatic pneumonitis in patients receiving TRT after PD‐(L)1 inhibitor treatment, which alerted radiation oncologists to delineate target plan carefully to control total lung V20 in order to minimize the incidence of pneumonitis when chose this sequential regimen.